Following the recovery from the impact of the COVID-19 pandemic, the European pain management device market will see moderate growth through 2032. Manufacturers in this space are actively…
The European infusion pump market would be primarily driven by factors such as the growing demand of non-hospital settings, which stimulate the demand for disposable and electronic ambulatory pumps…
Following recovery from the impact of the COVID-19 pandemic, the European neurostimulation device market will see modest growth through 2032, driven by ongoing product innovation and a focus on…
The Asia Pacific interventional oncology device market will see strong growth through 2032 driven by a large and rapidly expanding patient population, increasing popularity of minimally invasive…
The European interventional oncology device market will see moderate growth through 2032, driven by improved reimbursement, increasing popularity of minimally invasive surgeries, and growing…
Following recovery from the impact of the COVID-19 pandemic, the European neurostimulation device market will see modest growth through 2032, driven by ongoing product innovation and a focus on…
The US pain management device market is characterized by ongoing product innovation to improve treatment efficacy and to address new indications, with new clinical evidence and pain management…
The US neurostimulation device market is characterized by ongoing product innovation; iterative device improvements are regularly launching in established segments—such as the SCS and DBS device…
The COVID-19 pandemic has had a negative impact on the growth of the European diabetes care device market in the short term. However, the market is projected to be driven by the introduction of new…
The US diabetes care device market has shown strong recovery from the short-term negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the coming years. Market…
Global therapeutic BTX procedure volumes—and thus product sales and revenues—will be supported by the need for existing patients to return for maintenance procedures, as well as rising demand…
The US market for interventional oncology devices will grow through 2032. This will be driven largely by the increasing shift toward higher-priced technologies, such as radioembolization, and…
The COVID-19 pandemic has had a negative impact on the growth of the European diabetes care device market in the short term. However, the market is projected to be driven by the introduction of new…
The Japanese interventional oncology device market will grow slowly due to limited adoption of minimally invasive interventional oncology procedures, substantiated by Japanese guidelines and…
The COVID-19 pandemic has had a negative impact on the growth of the US infusion pump market in the short term. However, the market would be mainly driven by introduction of new technologies,…